Listed on GrantGunner. Last checked 15 Nov 2026.
About this grant
The Industry Innovation (I²) Fund provides risk capital and commercialization support for companies developing innovative life science technologies in British Columbia. Funding ranges from $500,000 to $1,750,000 per company in the form of hybrid debt and royalties, aimed at early-stage commercial development with a clear pathway to commercialization.
Who can apply
Companies must be beyond the research stage and in the commercial proof of concept or development phase. Funded companies can be based outside BC but must have a substantial presence in British Columbia.